Bharat Biotech COVID-19 Covaxin Gets DCGI Approval For Children Between 12-18 Years

New Delhi: In yet another boost to India’s vaccination spree, the Drugs Controller General of India (DCGI) has given emergency use approval to Bharat Biotech’s vaccine – Covaxin – for children aged between 12-18 years, official sources told ABP News.

The vaccine of Bharat Biotech was trialed in children in phases 2 and 3 and the subject expert committee had recommended it to be given to children.

The vaccine trial was divided into three age groups: 2 to 6, 6 to 12 and 12 to 18 years.

Covaxin is already included in the vaccination program and is being given to people over the age of 18.

(This is a developing story. More details awaited.)

Check out below Health Tools-
Calculate Your Body Mass Index ( BMI )

Calculate The Age Through Age Calculator


(This is an auto-generated article from syndicated news feed. TEAM BEPINKU.COM may not have modified or edited the article).

About the Author: TEAM BEPINKU.COM

We share trending news and latest information on Business, Technology, Entertainment, Politics, Sports, Automobiles, Education, Jobs, Health, Lifestyle, Travel and more. That's our work. We are a team led by Mahammad Sakil Ansari.

You May Also Like